Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)

NCT04465916 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
26
Enrollment
INDUSTRY
Sponsor class

Stopped DSMC reviewed results of 26 subjects. New randomizations were stopped. Already randomized subjects were followed up to W40.

Conditions

Interventions

Sponsor

Enyo Pharma

Collaborators